Back to Projects
pharmaceutical industry / healthcare
Organization of oncological pharmaceutical production
the project aims to establish a modern, GMP-certified pharmaceutical plant in Uzbekistan specialized in oncology treatments. The facility will feature high-tech production lines for cytotoxic (chemotherapy), monoclonal antibodies, and supportive care medicines. It includes advanced quality control laboratories and a dedicated R&D center for formulation development and biosimilars.
Client Country
Uzbekistan
Estimated Value
~80 mln EUR (≈85 mln USD)
Timeline
2026–2030 (estimated)
Scope of Services
Requested Services
- Feasibility study
- EPC support (engineering, procurement, construction)
- Project management (PM)
- GMP certification and international compliance assistance
Key Deliverables
- Chemotherapy drugs — 500,000 vials/year
- Monoclonal antibodies / biologics — 50,000 units/year
- Supportive care drugs — 200,000 units/year
- Total annual capacity: ~750,000+ units
Standards & Compliance
- GMP (good manufacturing practice)
- ISO 9001 (quality management system)
- Regulatory approvals from the Ministry of health of the Republic of Uzbekistan
Team & Partners
Lead Company
Ministry of Investment, industry and trade (Uzbekistan)
Funding & Support
Funding Status
Interested in This Project?
Contact the Caspian European Economic Forum to learn more about investment opportunities and partnership options.